Digital Health Raises $7.4B in H1 2026 as Megadeals Dominate: Rock Health

U.S. digital health companies raised $7.4 billion across 244 deals in the first half of 2026, according to Rock Health — surpassing the $6.4 billion raised in the same period last year on nearly identical deal volume.

The quarterly split tells its own story: $4.2 billion landed in Q1 against $3.2 billion in Q2, while the median deal size climbed to $14 million from $12 million in 2025. Fewer companies are raising, but the ones that do are raising bigger.

Mental health leads — again

Mental health held the top clinical funding position for the seventh consecutive year. Weight management ranked second, powered by continuing demand for GLP-1 medications and the digital wraparound services growing up alongside them.

AI is table stakes now

Perhaps the most telling detail in the report: Rock Health has stopped labeling AI as a distinguishing feature, because effectively every company claims it. As the analysts put it, AI "has made more tailored implementations possible, but has also flooded buyers with new options, raising expectations for measurable ROI."

Exits: plenty of M&A, no IPOs

The sector recorded 115 acquisitions in the first half — a healthy consolidation pace — but not a single IPO, though wearable maker Oura is reported to be approaching the line. For later-stage companies, the public-market window remains the sector's most-watched indicator for the back half of 2026.